The influence of anemia on clinical outcomes in venous thromboembolism: Results from GARFIELD-VTE.

[1]  W. Ageno,et al.  Age-sex specific pulmonary embolism-related mortality in the USA and Canada, 2000–18: an analysis of the WHO Mortality Database and of the CDC Multiple Cause of Death database , 2020, The Lancet Respiratory Medicine.

[2]  W. Ageno,et al.  Trends in mortality related to pulmonary embolism in the European Region, 2000-15: analysis of vital registration data from the WHO Mortality Database. , 2020, The Lancet. Respiratory medicine.

[3]  M. Toyofuku,et al.  Influence of baseline anemia on long-term clinical outcomes in patients with venous thromboembolism: from the COMMAND VTE registry , 2019, Journal of Thrombosis and Thrombolysis.

[4]  S. Goldhaber,et al.  Association of Anemia with Venous Thromboembolism in Acutely Ill Hospitalized Patients: An APEX Trial Substudy. , 2018, The American journal of medicine.

[5]  J. Bosson,et al.  Anemia and bleeding in patients receiving anticoagulant therapy for venous thromboembolism. , 2018 .

[6]  A. Wolberg,et al.  Red blood cells in thrombosis. , 2017, Blood.

[7]  W. Ageno,et al.  Global Anticoagulant Registry in the Field – Venous Thromboembolism (GARFIELD-VTE) , 2016, Thrombosis and Haemostasis.

[8]  Elie A Akl,et al.  Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report. , 2012, Chest.

[9]  H. Sørensen,et al.  Arterial cardiovascular events and mortality following venous thromboembolism. , 2015, Annals of translational medicine.

[10]  G. Raskob,et al.  Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism. , 2013, The New England journal of medicine.

[11]  Giancarlo Agnelli,et al.  Oral apixaban for the treatment of acute venous thromboembolism. , 2013, The New England journal of medicine.

[12]  G. Heinze,et al.  Hematocrit and the Risk of Recurrent Venous Thrombosis: A Prospective Cohort Study , 2010, PloS one.

[13]  Stef van Buuren,et al.  MICE: Multivariate Imputation by Chained Equations in R , 2011 .

[14]  Bruce L Davidson,et al.  Oral rivaroxaban for symptomatic venous thromboembolism. , 2010, The New England journal of medicine.

[15]  S. Goldhaber,et al.  Dabigatran versus warfarin in the treatment of acute venous thromboembolism. , 2009, The New England journal of medicine.

[16]  E. Oger,et al.  Venous thromboembolism (VTE) in Europe , 2007, Thrombosis and Haemostasis.

[17]  Luigi Ferrucci,et al.  Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia. , 2004, Blood.